Global law firm White & Case LLP has provided pro bono advice to Feebris Limited (Feebris), a London-based tech startup, on its first seed funding round.
"Feebris is another example of our pro bono commitment to the community tech sector and working with for-profit companies that have a social impact," said White & Case partner Emmie Jones, who led the Firm's deal team. "It showcases our ability to advise companies on every rung of the funding ladder, from seed financing to Europe's largest tech IPO."
Feebris is an AI company developing world-class machine learning algorithms for precision detection of complex respiratory conditions in the field. Their software platform pairs with existing medical sensors and can be used intuitively by those with little or no medical training, even outside a clinic environment, to detect respiratory issues. During a study in Mumbai in 2017, the team demonstrated with 1,300 children that their software could be used by community health workers to diagnose pneumonia with accuracy comparable to a hospital diagnosis via blood test and x-ray.
The funding round will support Feebris' AI-enabled platform to continue bridging the gap between the community and providers across a range of respiratory conditions including pneumonia, COPD and asthma.
The White & Case team in London which advised on the transaction was led by partner Emmie Jones with support from associate Joe Bradley.
For more information please speak to your local media contact.